VBI VACCINES INC (VBIV)
CA91822J2020 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 23.68M | 62.60M | 121.70M | 93.80M | 44.20M | |||
| Marketable Securities | N/A | N/A | 0.00 | 25.30M | N/A | |||
| Receivables | 1.27M | 4.10M | 1.40M | 100.00K | 200.00K | |||
| Inventories | 8.50M | 6.60M | 2.60M | 2.20M | 1.10M | |||
| Other Current Assets | 2.78M | 4.30M | 4.60M | 10.70M | 1.50M | |||
| Total Current Assets | 36.23M | 77.70M | 130.30M | 132.00M | 47.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 11.91M | 15.60M | 14.40M | 12.30M | 11.70M | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Goodwill | 1.13M | 2.10M | 2.30M | 2.30M | 2.20M | |||
| Intangibles | 36.50M | 58.30M | 62.10M | 62.20M | 60.80M | |||
| Other Non-Current Assets | 1.18M | 1.40M | 1.30M | 600.00K | 600.00K | |||
| Total Non-Current Assets | 50.72M | 77.40M | 80.00M | 77.40M | 75.20M | |||
| TOTAL ASSETS | 86.95M | 155.10M | 210.30M | 209.40M | 122.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 50.77M | N/A | N/A | 0.00 | 14.80M | |||
| Accrued Expenses | 6.60M | 14.80M | 16.10M | 12.20M | 12.10M | |||
| Accounts Payable | 6.43M | 13.00M | 4.30M | 3.70M | 1.10M | |||
| Other Current Liabilities | 11.93M | 9.20M | 12.20M | 1.40M | 1.70M | |||
| Total Current Liabilities | 75.74M | 36.90M | 32.60M | 17.30M | 29.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 48.90M | 28.40M | 16.30M | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 3.69M | 5.10M | 5.40M | 4.00M | 4.20M | |||
| Total Non-Current Liabilities | 3.69M | 54.00M | 33.80M | 20.40M | 4.10M | |||
| TOTAL LIABILITIES | 79.42M | 90.90M | 66.40M | 37.70M | 33.90M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -582.45M | -489.60M | -378.40M | -308.60M | -262.40M | |||
| Additional Paid In Capital | 107.43M | 90.00M | 81.60M | 75.50M | 66.40M | |||
| Common Shares | 454.21M | 442.30M | 442.20M | 403.50M | 285.00M | |||
| Other Shareholders' Equity | 28.33M | 21.40M | -1.60M | 1.30M | -800.00K | |||
| Shares Outstanding | 23.92M | 8.60M | 8.60M | 8.20M | 5.90M | |||
| Tangible Book Value per Share | -1.26 | 0.44 | 9.24 | 13.07 | 4.29 | |||
| Total Shareholders' Equity | 7.53M | 64.20M | 143.90M | 171.70M | 88.30M | |||
| TOTAL LIABILITIES AND EQUITY | 86.95M | 155.10M | 210.30M | 209.40M | 122.20M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | 0.76 | 0.20 | 0.09 | N/A | |||
| Current Ratio | 0.48 | 2.11 | 4.00 | 7.63 | 1.58 | |||
| Return On Assets (ROA) | -107.92% | -73.05% | -33.17% | -22.08% | -44.85% | |||
| Return On Equity (ROE) | -1246.73% | -176.48% | -48.47% | -26.92% | -62.07% | |||
All data in USD